In the News
Mr Henderson’s work in inherited retinal disease and gene therapy has been featured across national media. This page collects coverage as it is published.
Great Ormond Street Hospital · April 2026
NHS Eye Gene Therapy Restores Saffie’s Sight — GOSH Press Release
The official Great Ormond Street Hospital press release on Saffie Sandford’s Luxturna gene therapy, which restored her sight from the rare inherited condition Leber’s Congenital Amaurosis. References the JAMA Ophthalmology study and the GOSH–Moorfields joint service, and quotes Lisa Sandford: “we went ahead and put our trust in GOSH and in Rob.”
University College London · April 2026
Girl’s Sight Restored After ‘Life-Changing’ Gene Therapy — UCL News
UCL’s press release covering Saffie’s story and the accompanying research published in JAMA Ophthalmology — the largest UK study of its kind, following 15 children treated with Luxturna at GOSH between 2020 and 2023. Shows that treating younger children during a critical period of brain development produces the strongest results.
Pride of Britain Awards · May 2026
Saffie’s Story Featured by the Pride of Britain Awards
The Pride of Britain Awards — the UK’s highest-profile public recognition platform, screened annually on ITV — shared Saffie’s story across their social media channels, reaching hundreds of thousands of followers. The story has continued to circulate widely since the original April 2026 media coverage.
RNIB Connect Radio · May 2026
Life-Changing Eye Gene Therapy Makes a Real Difference to Saffie’s Vision
RNIB Connect Radio spoke with Mr Henderson and Saffie’s mother Lisa about Leber’s Congenital Amaurosis and the Luxturna gene therapy treatment performed at Great Ormond Street Hospital that restored Saffie’s vision. A 15-minute podcast that tells the story plainly and personally.